A new federal pathway coordinates insurance coverage with device approval, aiming to streamline a major access hurdle for breakthrough medical technologies nationwide.
Federal health agencies said the process could deliver coverage in as little as 2 mo, compared with timelines previously stretching >1 yr.
The pathway applies to breakthrough technology addressing unmet medical needs, after those devices already qualify for a quicker federal approval review track.
By bringing the insurance component earlier into development, the approach aligns approval reviews and coverage decisions before access delays build for patients.
For device developers, the key change is predictability: coverage discussions begin sooner, while approval review continues under one coordinated federal process pathway.
